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Abstract
Background: Although research productivity in the field of frailty has risen exponentially in recent years, there
remains a lack of consensus regarding the measurement of this syndrome. This overview offers three services: first,
we provide a comprehensive catalogue of current frailty measures; second, we evaluate their reliability and validity;
third, we report on their popularity of use.
Methods: In order to identify relevant publications, we searched MEDLINE (from its inception in 1948 to May 2011);
scrutinized the reference sections of the retrieved articles; and consulted our own files. An indicator of the
frequency of use of each frailty instrument was based on the number of times it had been utilized by investigators
other than the originators.
Results: Of the initially retrieved 2,166 papers, 27 original articles described separate frailty scales. The number
(range: 1 to 38) and type of items (range of domains: physical functioning, disability, disease, sensory impairment,
cognition, nutrition, mood, and social support) included in the frailty instruments varied widely. Reliability and
validity had been examined in only 26% (7/27) of the instruments. The predictive validity of these scales for
mortality varied: for instance, hazard ratios/odds ratios (95% confidence interval) for mortality risk for frail relative to
non-frail people ranged from 1.21 (0.78; 1.87) to 6.03 (3.00; 12.08) for the Phenotype of Frailty and 1.57 (1.41; 1.74)
to 10.53 (7.06; 15.70) for the Frailty Index. Among the 150 papers which we found to have used at least one of the
27 frailty instruments, 69% (n = 104) reported on the Phenotype of Frailty, 12% (n = 18) on the Frailty Index, and
19% (n = 28) on one of the remaining 25 instruments.
Conclusions: Although there are numerous frailty scales currently in use, reliability and validity have rarely been
examined. The most evaluated and frequently used measure is the Phenotype of Frailty.
Keywords: Frailty, Frail elderly, Measure, Overview, Reliability, Validity
Background
The global population of elderly people aged 60 years
or more was 600 million in 2000; it is expected to rise
to around 2 billion by 2050 [1]. With an aging popula-
tion, researchers are increasingly interested in frailty
[2,3], a syndrome characterized by age-related declines
in functional reserves across an array of physiologic
systems. Frail older adults experience an increased risk
of a number of adverse health outcomes such as co-
morbidity, disability, dependency, institutionalization,
falls, fractures, hospitalization, and mortality [4-21].
Identification of frail adults is important as trial evi-
dence suggest that frailty status might be reversible
with the implementation of exercise programs or hor-
mone treatment [22-25].
A series of frailty measures have emerged in recent
years. The aim of this overview is three-fold: 1) provide
a comprehensive catalogue of existing frailty measures;
2) review evidence on the validity and reliability of these
measures; and 3) quantify the popularity of each frailty
measure by investigators other than the originators.
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We took three approaches. First, we searched the elec-
tronic database MEDLINE (1948 to May 2011)
through the OvidSP interface for all articles using the
keyword “frailty” (using the term “frail” yielded an un-
manageably large literature with little relevance to the
present aims). This strategy allowed us to identify arti-
cles where this keyword appeared at least once in the
title, abstract, or subject heading. Second, the reference
sections of the retrieved articles were scrutinized for
additional relevant papers by manual searches. Third,
we searched our own records which included interro-
gation of our own relational databases (e.g. Reference
Manager, Endnote). This overview followed the guide-
lines for the Meta-analysis of Observational Studies in
Epidemiology (MOOSE) [26].
Selection criteria
We included studies with participants aged 50 years
and older at baseline examination in which the authors
purport to have measured frailty. Further inclusion cri-
teria were: 1) articles written in English, French, or
Spanish; and 2) articles describing the reliability and
validity of a frailty instrument.
Assessment of the reliability and validity of frailty
measures
The reliability and validity were assessed using sug-
gested guidelines [27,28]. Reliability, which determines
if a scale measures an entity (here frailty) in a repro-
ducible way, was investigated through the following
definitions: internal consistency (the average of the
correlations among all items in the measure), intra-
rater reliability (the agreement between observations
made by the same rater on two different occasions),
inter-rater reliability (the agreement between different
raters), and test-retest reliability (the agreement between
observations on the participants on two occasions sepa-
rated by an interval of time). Validity – whether the scale
in question measures what it purports to – was assessed
by criterion and construct validity. Criterion validity refers
to how well the instrument predicts an outcome. When
frailty and the outcome data are collected simultaneously,
the criterion validity is referred to as the concurrent vali-
dity. When the outcome data are prospectively col-
lected, it is called predictive validity. Finally, in this
context, construct validity refers to the extent to which
a frailty measure correlates with factors that are, based
on the extant literature, known to have an association
(e.g. age, comorbidity, disability, physical capabilities or
performances) [27,28].
Use of frailty measurements by researchers
To evaluate the level of utilization of a given frailty in-
strument by researchers, we counted, among the se-
lected articles, the number of publications which had
been authored by researchers other than the originators
in the periods ≤ 2000, 2001-2005, and ≥2006. In addition
to this, we used the Scopus citation database [29] of
peer-reviewed literature to analyze the number of cita-
tions in original research articles, excluding those cited
by the creators of a given frailty instrument, for each
frailty scales up to October 2011. In order to have an
indication about the level of predictive validity of the
identified frailty instruments, estimates – hazard ratios
(or relative risks) and odds ratios – for the association
between a frailty score and an adverse health outcome,
in particular mortality, were examined.
Results
The initial keyword search using “frailty” identified 2,166
articles (Figure 1). Based on the content of the title and
the abstract, 1,509 articles were excluded for the follow-
ing reasons: article not published in English, French, or
Spanish; article untraceable; studied population not of
interest (animals, non-elderly population); statistical
methods paper; or topic of the articles was not focused
on measurement of frailty but its mechanism, predictors,
prevention, intervention, and management/treatment. A
further 209 papers were excluded because they were
reviews rather than empirical papers. Of the remaining
448 articles, 27 [30-56] described the construction or
psychometric properties of measures of frailty, and were
included in this review. Among them, five instruments
initially created to assess disability [57], vulnerability
Figure 1 Phases of the literature search.
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[58], and physical capabilities or performances [59-61]
were used subsequently to assess frailty [36,39,41,42,44].
For these five instruments, their reliability, validity, and
use were studied as a measure of frailty. A further 150
articles either applying or testing the validity of these 27
frailty measurements were included in our synthesis.
Classifications: self-report, objective, and mixed frailty
measures
All 27 identified frailty measurements were grouped into
three categories (Additional file 1: Table S1): subjective
(self-reported items only), objective (inclusion of only
directly measured components), or subjective and ob-
jective combined (mixed). Eleven of the 27 instruments
included only subjective components which were either
reported by a participant (self-evaluation) in nine out of
11 cases [30-34,36,38-40], or reported by a clinician
or a researcher (hetero-evaluation) [35,37]. Of the 27
frailty instruments, five included only objective com-
ponents [41-45]. Finally, the remaining 11 instruments
included both subjective and objective (mixed) com-
ponents [46-56].
General description of frailty measurements
Of the 27 frailty assessments, 19 were developed in popula-
tion-based samples [30-32,34-37,40-44,46-48,50,51,53,55],
7 among hospitalized patients [33,39,45,49,52,54,56], and 1
without specification [38]. Half of the frailty scales (n=14)
were created by research groups in the USA [30,
31,36,39,41-44,46-49,53,56], five in Canada [32,34,37,52,54],
three in the Netherlands [33,40,51], two in Italy [38,45],
and one each in Australia [55], France [50], and Sweden
[35]. Five of the 27 frailty instruments were adapted from
those developed initially to assess functional status [57],
vulnerability [58], or physical performances [59-61]. These
were used to measure frailty for the first time by Cacciatore
and colleagues [36], Kanauchi and colleagues [39], Brown
and colleagues [41], Gill and colleagues [42], and Bandinelli
and colleagues [44], respectively. Furthermore, recently
tested tools assessing frailty such as Static/Dynamic Frailty
Index [51], Study of Osteoporotic Fractures Index [53],
FRAIL scale [55], and Comprehensive Assessment of Frailty
[56] were based on the Fried’s frailty scale [47] and/or the
Mitnitski’s Frailty Index [34].
All identified frailty measures were composed of at
least two items, except that of Gerdhem and colleagues
[35] where a general assessment of health is made within
a 15-second observation by the investigator. Of the
subjective and mixed frailty measures, most contained
disability and/or comorbidity components. Instruments
without disability or comorbidity information were: the
1994 Frailty Measure [31], Subjective Frailty Score [35],
Tilburg Frailty Indicator [40] all objective measures
(Modified Physical Performance Test [41], Physical Frailty
Score [42], Klein’s frailty index [43], Short Physical Per-
formance Battery [44], and Opasich’s frailty scale [45]),
Speechley & Tinetti’s frailty scale [46], Fried’s frailty scale
[47], Score-Risk Correspondence for dependency [50],
Study of Osteoporotic Fractures Index [53], and Brief
Frailty Index [54]. Further descriptions of characteristics
of population and type of components included in each in-
strument are also provided in (Additional file 1: Table S1).
Assessment of the reliability and validity of frailty
measures
Additional file 2: Table S2 presents reliability and vali-
dity data taken from the original articles and other
related articles on the frailty measurements. Three ap-
proaches were used for reliability assessment: internal
consistency, inter-rater, and test-retest reliability. Con-
current and predictive validity were mainly assessed
using outcomes such as mortality, institutionalization,
activities of daily living (ADL) disability, hospitalization,
and quality of life. Only 7 out of 27 instruments (26%)
were found to have had both reliability and validity
ascertained [33,35,37,40,43,49,52].
Of all, 19 instruments had either their reliability or
validity assessed. Among them, 4 instruments were
tested for validity only once in the original sample/co-
hort of participants [32,36,55,56], and the Phenotype of
Frailty by Fried and colleagues [47] and the Frailty Index
by Mitnitski and colleagues [34] had their concurrent or
predictive validity assessed in more than 3 samples/co-
horts (17 and 13 samples/cohorts, respectively). One in-
strument out of 27, the Short Physical Performance
Battery, previously used to assess physical functioning
[61], had neither reliability nor validity information in
measuring frailty [44].
Information on the predictive validity was available for
16 instruments. In 69% (n=11/16), the predictive validity
was quantified by relating the frailty measure to mortal-
ity. With average follow-ups varying from 1 month to 12
years, hazard ratios or relative risks (from Cox regres-
sion) or odds ratios (from logistic regression) for mortal-
ity risk for frail people relative to those with no record
of the condition ranged from 1.21 (95% confidence inter-
val (CI): 0.78; 1.87) to 6.03 (95% CI: 3.00; 12.08) for the
Phenotype of Frailty [47] and 1.57 (95% CI: 1.41; 1.74) to
10.53 (95% CI: 7.06; 15.70) for the Frailty Index [34].
The Phenotype of Frailty has been rarely used in a con-
tinuous fashion. One exception is Kulminski et al who
found an increased mortality risk of 2% (RR=1.02; 95%
CI: 1.02; 1.03) for a one unit of increase in this scale. For
the Frailty Index, the estimates ranged from 1.008 (95%
CI: 1.005; 1.011) to 10.53 (95% CI: 7.06; 15.70). The
estimates – hazard ratios (or relative risks) and odds
ratios – examining the association between a frailty
score and mortality do not allow to affirm which score is
Bouillon et al. BMC Geriatrics 2013, 13:64 Page 3 of 11
http://www.biomedcentral.com/1471-2318/13/64
the best in the prediction of mortality for several rea-
sons: 1) relative risks and odds ratios are calculated
differently [62]; 2) estimates were assessed in different
populations, therefore with different baseline risks;
3) follow-ups and adjustment for confounding factors
were heterogeneous. In spite of these limits, the esti-
mates in Additional file 2: Table S2 give a qualitative ap-
preciation on the magnitude of the association between
a frailty score and mortality.
Use of frailty instruments
Additional file 3: Table S3 presents the number of publica-
tions in which a frailty measure had been used by
investigators other than those who created it. In 69% of
publications, a frailty scale developed by Fried and
colleagues [47] was utilized; 12% used the Frailty Index
developed by Mitnitski and colleagues [34]; 4% the
Edmonton Frail Scale [52]; and ≤ 2% used the remaining
instruments. This analysis also shows that half the frailty
instruments (n=14) have not been employed at all by
other researchers [30,35,36,38,43-45,48-51,54-56]. Figure 2
displays the number of original research articles based on
the Scopus citation database, which referenced one of the
27 frailty instruments: the 3 most cited papers were that
of Fried and colleagues, 2001 [47] (n=676), Speechley and
colleagues, 1991 [46] (n=167), and Gill and colleagues,
2002 [42] (n=150). The citation rank for Mitnitski and col-
leagues’ paper, 2002 [34] was ninth (n=52).
Discussion
In this overview, we aimed at providing a comprehen-
sive catalogue of frailty measures, reviewing evidence
on their validity and reliability, and quantifying the
use of each measure by investigators other than the
originators. We identified 27 frailty scales used in 150
studies to date. We made a series of observations.
First, although frailty, disability, and comorbidity are
inter-related, they are distinct clinical entities [63,64].
Integrating disability or comorbidity items into a
frailty scale may be debatable as they are not equiva-
lent concepts. However, half the frailty instruments
(n=14) include either disability or comorbidity com-
ponents [30,32-34,36-39,48,49,51,52,55,56]. Second, at
least five measures [36,39,41,42,44] of frailty were
originally created to measure vulnerability, functional
status, and physical performances, suggesting a lack
of terminological rigor. Third, we observed that four
recent scales [51,53,55,56] are based on existing mea-
sures, in particular the Fried scale. Finally, confusion
between frailty scales can be generated because some-
times a specific instrument is named differently in
different studies (the Fried scale [47] being labelled as
Fried Frailty Index [65] on occasion). Elsewhere, se-
veral instruments are identically named but have different
item content: for instance, the term “frailty index” was
used by different researchers [34,43,54]. This was also the
case with “frail scale” [52,66].
Figure 2 Number of original research articles citing individual frailty instruments according to the Scopus Citation Database,
October 2011.
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Assessment of the reliability and validity of frailty
measures
The Standards for Educational and Psychological Testing
[67], a guideline which describes the best practice in the
development of complex measures such as frailty, re-
commends the reporting of the basic principles of test
construction such as reliability and validity. However,
this information was available only for a few instru-
ments: CSHA Clinical Frailty Scale [32] and Edmonton
Frail Scale [52]. They had acceptable reliability (Kappa
coefficient ≥ 0.7) and good concurrent and predictive
validity. Two instruments were widely tested for their
validity but not reliability: the Frailty Index [34] and the
Fried’s scale [47]. Reliability and validity are the most
important indicators when selecting one measure over
another. However, even among 7 frailty measurements
with such information [33,35,37,40,43,49,52], none of
them appear to be recognized as a “gold standard”. Com-
paring the performances of different frailty scales in
predicting an objective health outcome such as mortality
was complicated by the use of different confounding
factors across studies.
In several studies, investigators have examined the
inter-relationships between different measures of frailty.
Thus, the Fried’s scale has been compared with the
Frailty Index [10,68,69] and the Study of Osteoporotic
Fracture index [15,53] using different methods: corre-
lation analyses [69], comparison of strength of cross-
sectional [68] and prospective associations [10,15], and
use of the c-index statistic [53]. The Fried’s scale is mo-
derately well correlated with the Frailty Index [69], and
shows a stronger association with age and sex (impor-
tant criteria of construct validity [28]) [68] but a weaker
association with mortality [10]. The Fried’s scale and
the Study of Osteoporotic Fracture index have a
similar strength of association with falls, disability,
hospitalization [15] and death [53]. As Streiner and
Norman [27] highlighted, we found that it was some-
times difficult to disentangle whether an assessment
belongs to concurrent validity or construct validity. There-
fore, certain classifications in either category might
be arguable.
Use of the frailty instruments
We attempted to assess the use of a frailty instrument
by counting the number of publications that had
adopted the instrument other than the original creators.
The two instruments which have had their external
validity most extensively evaluated against adverse
health outcomes were those developed by Fried group
(Phenotype of Frailty) and Mitnitski group (Frailty
Index). These are based on two different conceptual
frameworks. The Fried group has suggested that frailty
represents a phenotype which reflects underlying age-
related changes in multiple systems. By contrast, the
Mitniski group advances that frailty is the accumulation
of multiple deficits, with the degree of frailty denoted by
the number of such deficits. This highlights that al-
though some investigators recognize that frailty, comor-
bidity, and disability are distinct entities [28,47,70], for
others they are overlapping. Most reviews or editorials
on frailty have implicitly presented the Phenotype of
Frailty as standard [63,71-81] whereas for others the
standard is the Frailty Index [82,83]. Recommendations
from other researchers are more nuanced. For Sternberg
and colleagues [84], the choice depends on the defi-
nition and outcomes that best suit the investigators or
clinicians responsible for the screening. The European,
Canadian and American Geriatric Advisory Panel [66]
recommend using a hybrid measure, the “FRAIL” scale,
comprising components from both the Phenotype of
Frailty and the Frailty Index.
The Fried’s scale [47] has been the most extensively
tested for its validity and is the most widely used instru-
ment in frailty research [65,78,85-134]. Randomized con-
trolled trials have also used the scale to screen elderly
participants [24,25,135-140], or as an outcome of inter-
ventions [22,23,139]. The Fried’s scale is widely used,
allowing comparisons to be made between studies.
The main limitation of our assessment of use of these
instruments is that it penalizes the more recently pub-
lished frailty instruments. However, the Fried’s scale is
not the oldest measure in the field and several more
recent frailty instruments are either derived or similar to
that measure, suggesting that qualities other than du-
ration of availability explain the popularity of this instru-
ment. Another limitation lies in the lack of elimination
of articles that may have resulted from the original au-
thors’ circle of influence. For example, some of the arti-
cles which report on the use of the Fried’s scale may
have been produced from former co-workers who had
previously utilized the CHS data – the dataset in which
the Fried’s scale was first validated.
In spite of its wide use, the Fried’s scale has some
drawbacks common to other frailty instruments. Chiefly,
different scales utilize different classification of the indi-
vidual components. For example, in the Cardiovascular
Health Study (CHS), participants were considered posi-
tive for weight loss if they reported having lost more
than 10 pounds unintentionally in the last year or they
objectively lost 5% or more in comparison with the pre-
vious year’s body weight [47]. In Women’s Health Aging
Study-I, however, a cut-off of 10% in comparison with
the self-reported weight at age 60 years [4] was utilized.
These important variations in the operationalization of
frailty measurement render comparisons of findings be-
tween studies as problematic.
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In addition to the manual counting procedure to esti-
mate the use of the frailty instruments, we also exam-
ined the number of citations in original research articles
(excluding those cited by the creators of a given frailty
instrument) for the 27 papers describing the frailty in-
struments. Even though the rank of citations was diffe-
rent for some of the frailty instruments than that of the
manual counting, the paper on the Fried’s scale was still
the most highly cited. Although the number of citations
can be easily accessed, this electronic database search
cannot replace the manual counting method as the pa-
pers citing the original articles do not necessarily use the
tool in question.
Among previously published reviews [66,83,84,141-145]
on frailty measures, only one [83] assessed them in terms
of reliability and validity. Compared with the De Vries and
colleagues’ paper [83], our review presents additional
strengths. First, to evaluate reliability and validity of a
given instrument, we have extracted data from other stu-
dies, reflecting its level of external validation. Second, to
our knowledge, no article has been published on the
extent to which frailty measures have been used by other
researchers. This finding might reflect the level prefer-
ence of researchers for a given frailty measurement
in the absence of a consensually recognized tool.
Moreover, we identified 18 other frailty instruments
[30,32,35-38,40-46,48,52,54-56], 5 of them created in
2010 and after. Another limitation of our review may lie
in the use of a unique keyword “frailty” to identify rele-
vant publications on frailty measurements. One may
find such a strategy restrictive, leading to miss some
screening tools helping to identify frail elderly. In fact,
we included similar frailty instruments than those com-
prised in the recent reviews [83,84].
Conclusions
This review provides a comprehensive overview of
existing frailty measurements. We identified 27 mea-
sures of frailty but none of them have been recog-
nized as a gold standard. Difficulties in accepting one
measure as a reference may lie in the following
reasons: the existence of frailty as a clinical entity is
quite new; the definition of frailty is still debatable,
therefore, it is difficult to create a composite measure
that would meet all criteria. Components to include
in the frailty instruments need to be further discussed
to reach a consensus, in particular on whether to in-
clude disability and/or disease data. The most widely
used frailty measurements by investigators [34,47],
such as the frailty scales developed by Fried and
colleagues and Mitnitski and colleagues need to be
further assessed, including attempts to improve them,
before being recognized as a gold standard.
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